Comparing lignocaine lozenges and oral zinc dispersible tablet to reduce the manifestation of post operative sore throat following I-gel insertio
- Conditions
- Health Condition 1: PCS- Health Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2022/08/044849
- Lead Sponsor
- DR NAVAMI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients posted foe elective surgeries under general anesthesia
ASA PS grade 1 and 2
Low and moderate risks surgeries of duration more than or equal to 30 minutes to less than or equal to 2 hours
patients refusal to consent
patients with pregnancy, altered coagulation profile/ bleeding diathesis, Smokers, Recent history of sore throat or upper respiratory tract infection
Mallampatti grade 3 or more
Body mass index of 35 or greater
Allergy to zinc tablet or local anesthetics
Increased risk of aspiration such as gastroesoghageal reflux disease
Trauma to airway
Alcoholism , drug abuse , psychological or other emotional problems that are likely to invalidate the informed consent or limit the ability of the subject to comply with the protocol requirements will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of post operative sore throat is studied using verbal rating scale 0 to 3, 0 equals to no sore throat, 1 equals to mild sore throat on questioning , 2 equals to moderate degree of sore throat complaints of his or her own , 3 equals to severe sore throat change in voice, hoarseness and throat painTimepoint: Immediate post operative period , 2hours , 4hours, 24 hours post operative respectively
- Secondary Outcome Measures
Name Time Method Severity of post operative sore throat , incidence of cough and other undesirable side effectsTimepoint: Immediate post operative period , 2hours, 4hours, 24hours post operative respectively